Cargando…

Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2

Immunization with vesicular stomatitis virus (VSV)-vectored COVID-19 vaccine candidates expressing the SARS-CoV-2 spike protein in place of the VSV glycoprotein relies implicitly on expression of the ACE2 receptor at the muscular injection site. Here, we report that such a viral vector vaccine did n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taddeo, Adriano, Veiga, Inês Berenguer, Devisme, Christelle, Boss, Renate, Plattet, Philippe, Weigang, Sebastian, Kochs, Georg, Thiel, Volker, Benarafa, Charaf, Zimmer, Gert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309237/ https://www.ncbi.nlm.nih.gov/pubmed/35879345 http://dx.doi.org/10.1038/s41541-022-00508-7

Ejemplares similares

Enhanced Fitness of SARS-COV-2 Variant of Concern Alpha in Mouse Strains Expressing the Human Angiotensin-Converting Enzyme 2
por: Taddeo, A., et al.
Publicado: (2022)

Serpinb1a Is Dispensable for the Development and Cytokine Response of Invariant Natural Killer T Cell Subsets
por: Leborgne, Nathan G. F., et al.
Publicado: (2020)

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both
por: Beitari, Saina, et al.
Publicado: (2023)

Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans
por: Poetsch, Joseph H, et al.
Publicado: (2019)

The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype
por: Barut, G. Tuba, et al.
Publicado: (2022)

Insights from the Infection Cycle of VSV-ΔG-Spike Virus
por: Milrot, Elad, et al.
Publicado: (2022)

Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein
por: Li, Hongyue, et al.
Publicado: (2021)

The viral vector vaccine VSV-GP boosts immune response upon repeated applications
por: Tober, R, et al.
Publicado: (2012)

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization()
por: Dahlke, Christine, et al.
Publicado: (2017)

Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

Tumor-induced inflammation alters neutrophil phenotype and disease progression
por: Benarafa, Charaf
Publicado: (2015)

Regulation of Neutrophil Serine Proteases by Intracellular Serpins
por: Benarafa, Charaf
Publicado: (2015)

Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
por: Qiu, Xiangguo, et al.
Publicado: (2009)

VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2023)

To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
por: Pinski, Amanda N., et al.
Publicado: (2020)

Envelope-Specific Adaptive Immunity following Transplantation of Hematopoietic Stem Cells Modified with VSV-G Lentivirus
por: Rust, Blake J., et al.
Publicado: (2020)

Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2022)

Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency
por: Hirsiger, Julia R., et al.
Publicado: (2022)

Immunogenicity of a recombinant VSV-Vectored SARS-CoV vaccine induced robust immunity in rhesus monkeys after single-dose immunization
por: Shan, Dan, et al.
Publicado: (2022)

CXCL14: the Swiss army knife chemokine
por: Benarafa, Charaf, et al.
Publicado: (2015)

Usp18 Expression in CD169(+) Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV
por: Friedrich, Sarah-Kim, et al.
Publicado: (2020)

Transcriptional profiling of immune responses in NHPs after low-dose, VSV-based vaccination against Marburg virus
por: Prator, Cecilia A., et al.
Publicado: (2023)

Optimization of VSV‐ΔG‐spike production process with the Ambr15 system for a SARS‐COV‐2 vaccine
por: Rosen, Osnat, et al.
Publicado: (2022)

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
por: Steeds, Kimberley, et al.
Publicado: (2020)

rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits
por: Rosner, Amir, et al.
Publicado: (2022)

Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
por: Ulrich, Lorenz, et al.
Publicado: (2021)

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
por: Kapadia, Sagar U., et al.
Publicado: (2005)

Neutrophils: Between Host Defence, Immune Modulation, and Tissue Injury
por: Kruger, Philipp, et al.
Publicado: (2015)

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2020)

Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography
por: Lerer, Elad, et al.
Publicado: (2021)

The specific features of the developing T cell compartment of the neonatal lung are a determinant of respiratory syncytial virus immunopathogenesis
por: Démoulins, Thomas, et al.
Publicado: (2021)

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV
por: Rechtien, Anne, et al.
Publicado: (2017)

SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus
por: Havranek, Katherine Elizabeth, et al.
Publicado: (2020)

Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate
por: Makovitzki, Arik, et al.
Publicado: (2021)

Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots
por: Gillespie, Paul F., et al.
Publicado: (2023)

Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses
por: Ouyang, Maggie Jing, et al.
Publicado: (2023)

Development and Applications of VSV Vectors Based on Cell Tropism
por: Tani, Hideki, et al.
Publicado: (2012)

Titration methods for rVSV-based vaccine manufacturing
por: Gélinas, Jean-François, et al.
Publicado: (2020)

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine
por: Santoro, Francesco, et al.
Publicado: (2021)

SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility
por: Zhou, Bin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bnei7graupk56f94t7g8t9tv54